Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

902 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Urine LOX-1 and Volatilome as Promising Tools towards the Early Detection of Renal Cancer.
Murdocca M, Torino F, Pucci S, Costantini M, Capuano R, Greggi C, Polidoro C, Somma G, Pasqualetti V, Ketchanji Mougang Y, Catini A, Simone G, Paolesse R, Orlandi A, Mauriello A, Roselli M, Magrini A, Novelli G, Di Natale C, Sangiuolo FC. Murdocca M, et al. Among authors: costantini m. Cancers (Basel). 2021 Aug 21;13(16):4213. doi: 10.3390/cancers13164213. Cancers (Basel). 2021. PMID: 34439368 Free PMC article.
Zero-ischemia minimally invasive partial nephrectomy.
Simone G, Ferriero M, Papalia R, Costantini M, Guaglianone S, Gallucci M. Simone G, et al. Among authors: costantini m. Curr Urol Rep. 2013 Oct;14(5):465-70. doi: 10.1007/s11934-013-0359-0. Curr Urol Rep. 2013. PMID: 23893291 Review.
AMBRA1 and SQSTM1 expression pattern in prostate cancer.
Falasca L, Torino F, Marconi M, Costantini M, Pompeo V, Sentinelli S, De Salvo L, Patrizio M, Padula C, Gallucci M, Piacentini M, Malorni W. Falasca L, et al. Among authors: costantini m. Apoptosis. 2015 Dec;20(12):1577-86. doi: 10.1007/s10495-015-1176-3. Apoptosis. 2015. PMID: 26423274 Free PMC article.
Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
Simone G, Tuderti G, Anceschi U, Papalia R, Ferriero M, Misuraca L, Minisola F, Mastroianni R, Costantini M, Guaglianone S, Sentinelli S, Gallucci M. Simone G, et al. Among authors: costantini m. World J Urol. 2017 May;35(5):789-794. doi: 10.1007/s00345-016-1923-2. Epub 2016 Aug 30. World J Urol. 2017. PMID: 27578234
Secreted miR-210-3p as non-invasive biomarker in clear cell renal cell carcinoma.
Petrozza V, Pastore AL, Palleschi G, Tito C, Porta N, Ricci S, Marigliano C, Costantini M, Simone G, Di Carlo A, Gallucci M, Carbone A, Fazi F. Petrozza V, et al. Among authors: costantini m. Oncotarget. 2017 Jun 13;8(41):69551-69558. doi: 10.18632/oncotarget.18449. eCollection 2017 Sep 19. Oncotarget. 2017. PMID: 29050224 Free PMC article.
Renal cancer: new models and approach for personalizing therapy.
di Martino S, De Luca G, Grassi L, Federici G, Alfonsi R, Signore M, Addario A, De Salvo L, Francescangeli F, Sanchez M, Tirelli V, Muto G, Sperduti I, Sentinelli S, Costantini M, Pasquini L, Milella M, Haoui M, Simone G, Gallucci M, De Maria R, Bonci D. di Martino S, et al. Among authors: costantini m. J Exp Clin Cancer Res. 2018 Sep 5;37(1):217. doi: 10.1186/s13046-018-0874-4. J Exp Clin Cancer Res. 2018. PMID: 30185225 Free PMC article.
902 results